2026-10-09

Triastek Announces Strategic Collaboration and Equity Investment to Advance the Development of Oral Medicines

2026-04-01

Triastek Receives FDA IND Clearance for T25 Octreotide Acetate Tablet

2026-03-25

Triastek Receives FDA IND Clearance for T26 Itraconazole Tablet, a 3D Printed Solubility-Enhancing Drug Product

2025-03-17

Triastek's 3D-Printed Gastric Retention Product T20G Receives FDA IND Clearance

2025-02-20

Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results

2024-07-29

Triastek 3DP Intelligent Pharmaceuticals